Multidrug resistant (MDR) P. aeruginosa had emerged in Egypt and seen mainly in
nosocomial infections due to the selective pressure by overusage of antibiotics. This study …

Purpose Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (P.
aeruginosa) is a major health-care problem. In this study, we explored the epidemiology of …

Purpose. The molecular epidemiology and resistance mechanisms of carbapenem-resistant
Pseudomonas aeruginosa (CRPA) were determined in hospitals in the countries of the Gulf …

Recent studies have focused on the decreased susceptibility of Pseudomonas aeruginosa
to currently used anti-pseudomonal agents, including β-lactams, aminoglycosides and …

Predictors of mortality and the impact of multidrug resistance and virulence on patients with
Pseudomonas aeruginosa (PA) bacteraemia were evaluated. Patients with PA bacteraemia …

Objectives MDR Pseudomonas aeruginosa is a serious global threat to healthcare
institutions. The mechanism by which drug resistance can be acquired is variable, but …

Introduction Carbapenems are the beta-lactam antibiotics with the best spectrum of activity
in the treatment of Pseudomonas aeruginosa infections. The objective of this study was to …

Objectives Pseudomonas aeruginosa is a leading cause of community-and hospital-
acquired infections. Successful treatment is hampered by its remarkable ability to rapidly …

Abstract Background The SENTRY Antimicrobial Surveillance Program was established in
1997 and encompasses over 750 000 bacterial isolates from≥ 400 medical centers …

Pseudomonas aeruginosa is one of the most common nonfermenting aerobic gramnegative
microorganisms identified in clinical specimens of hospitalized patients. The emergence of …